Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,952,954
+$535,927 QoQ
Shares Held
908,351
0.0% QoQ
Ownership
0.818%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. ALEC ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
580,678 | $56,470,935 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
978,463 | $20,978,246 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
476,740 | $15,884,976 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $14,582,391 | |
| 5 | CYTK |
Cytokinetics Inc
|
217,497 | $14,335,227 | |
| 6 | NKTR |
Nektar Therapeutics
|
165,178 | $11,884,557 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
443,829 | $9,586,706 | |
| 8 | LRMR |
Larimar Therapeutics, Inc.
|
2,029,164 | $9,131,238 |
All Filings in ALEC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,952,954 | 908,351 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,417,027 | 908,351 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,363,118 | 798,351 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,278,099 | 912,928 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,122,901 | 912,928 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,725,433 | 912,928 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,254,244 | 912,928 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,144,693 | 912,928 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,495,826 | 912,928 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,867,041 | 609,905 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,075,518 | 628,938 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,840,017 | 638,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,667,191 | 592,438 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,914,402 | 532,438 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,036,863 | 532,438 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,612,770 | 552,438 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,171,644 | 292,747 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,205,850 | 155,247 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,451,141 | 107,412 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $2,567,850 | 127,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,929,075 | 127,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,474,900 | 140,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,421,600 | 140,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,740,150 | 155,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||